{"name":"Kindeva Drug Delivery","slug":"kindeva","ticker":"Private","exchange":"Private","domain":"kindevadd.com","description":"Kindeva Drug Delivery is a contract development and manufacturing organization (CDMO) specializing in drug delivery solutions. The company focuses on developing innovative formulations and delivery systems for various therapeutic areas. With a strong presence in the market, Kindeva Drug Delivery provides services to pharmaceutical companies worldwide. Its expertise in drug delivery enables clients to bring new treatments to market efficiently and effectively.","hq":"Woodbury, MN","founded":0,"employees":"","ceo":"Benjamin McGraw","sector":"Drug Delivery / CDMO","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"~$2B (private valuation)","metrics":{"revenue":480000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"EpiPen patent cliff ($1.5B at risk)","drug":"EpiPen","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-22","type":"deal","headline":"Kindeva Drug Delivery Acquires Catalent's Oral Dosage Business","summary":"Kindeva Drug Delivery has acquired Catalent's oral dosage business, expanding its capabilities in drug delivery solutions.","drugName":"","sentiment":"positive"},{"date":"2023-09-14","type":"regulatory","headline":"Kindeva Drug Delivery Receives FDA Approval for New Drug Product","summary":"Kindeva Drug Delivery has received FDA approval for a new drug product, marking a significant milestone in its growth.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPSlJxaVRvZF9zZVNNWERhMHpxOW9qRHpWSk1mSlQyQ0hjYk1vTVAtUmpZNTJlZWFfem9rX2tvdjFtQktJbDVXNlowREUyeFFhRGdJQTRBazJmdVhoazZyU3hZbEllMzZuSW41djkyLUNmdWlob2owQXVwRVhCb2pkeE42MFVNUW9UTXIw0gGfAUFVX3lxTE1ZdFlIYk1nV1dLSVEweF9WVjdNdDVrZHhtOGMzUVNsMmRNSzlUcFd5TzNfV1lYcDZEdUI5TlB0Vm9QcW8yY3JMN0JTd2dnRFpVZUtSanV2WGtIMVZvZWZtemJfVVVkalZ5bUQ3MWVLeHdXR0NNb3ZQaUVjX0RROV9sR29fSzFPUEJzTDQ4ODJYZFRGYUc5M2NXdWNBV1NZbw?oc=5","date":"2025-05-01","type":"pipeline","source":"WKYT","summary":"Kindeva drug delivery company holds ribbon cutting - WKYT","headline":"Kindeva drug delivery company holds ribbon cutting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxQd1pYeXlKcXpnNmpRU0s3N2pfaVVwV01ITUJnYlMyY253LURiUDducWlndm41R1VUSXZJbnBvQ3M2aXJWclRBRXhZbkFkWHF1MzZmRWw0Zk9Cbk5iM0NlTzNYRXkwOVRCTkx6WmRKTkY2TUZQbTBJel9QNGhFcVhrQUV2a1M0cmU0RXhkWFVydFZ5dzZld1V1cGx4eEFEUm8xaG4tYUh3Q1RSWUxFREJzancyV0xUT0U1LVpnMlpDajYxS0M1NlJteXU0TXBVUVFkWXFicFZ5RnN5bGpZZU5NbXNZSFM5ODc5S1JMeXVMMUlleURpelpJMmZnajVmUQ?oc=5","date":"2025-02-02","type":"pipeline","source":"BioSpace","summary":"Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System - BioSpace","headline":"Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delive","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPNEpKSTY0SzQ3UXVaRjFKcC0wT1BZcG9jN2liM1A2YjBveGdWMEUtamVVRzU0aXJ0WFhERFVsYzBqYkg0ai1Wc0N5Nzd4V1VoRXFELWYtd0JCdWQ1SDNVbkZhNHhySG82WWdpMEVYWHJOV3ZUTUs5TU5WcExZdFhRdC1vUlpBOXIwM3A2VQ?oc=5","date":"2024-02-26","type":"pipeline","source":"Private Equity Stakeholder Project PESP","summary":"Private Equity Health Care Acquisitions – January 2024 - Private Equity Stakeholder Project PESP","headline":"Private Equity Health Care Acquisitions – January 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNaGFRMHFFVlBvMWJDa2x0b1Fzb0FiVTBMVDFWem52YWRIS3V1a0RnUnQ4V0hpU2QtMTdMLTAyOC02LWV5dWd2NzZzNDlMTkhXRmxvazhVMUY4SERoV2E0YmxmNFBhR1J1N3BxNDN2anpSYXVfZlZXQXZYcW9OY2loMTVITDlZeW1GMEpibTg2TmNDaGVYX2ZLNjlqZk1leWR1ekE?oc=5","date":"2024-01-31","type":"deal","source":"Contract Pharma","summary":"Pharmaceutical Industry Mergers & Acquisitions Roundup - Contract Pharma","headline":"Pharmaceutical Industry Mergers & Acquisitions Roundup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOMFVGbTQ3Y0R0RjdhTnFCMHlFci1DNkgxSWV1RC1WS2ZCOHJPeTBEZU80TmdPVzVHODBSQW93X3E2SXJrclhDbldoTmpGa2ZKVTJ3SEk5RHF1dlFqcDd5aVQ1OW9DUlRjOEgxUzNTQ3J1NG9ZVnBuNFFlVC1VTVFXTDkxOXVHQkQ0czBFNWlveUpUUVZhdm5tMVVZMzZrdkp0YjRXa0lOUEtVUU1QODdDUkYtOXhOZ2J2WW8zbWpwa2tZYmpITGZaX3lCMVVQX05TTkE?oc=5","date":"2023-09-15","type":"pipeline","source":"Business Wire","summary":"Kindeva Drug Delivery Appoints Brian Schubmehl as Chief Human Resources Officer - Business Wire","headline":"Kindeva Drug Delivery Appoints Brian Schubmehl as Chief Human Resources Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNbjB1Ujdhc3hrNVNBTVVjeHlmTDNUTkZNN3I3cTMxX3pZQWF1M001MzBpMC0tMy0wLTZoQTFPX1pmVFpPMXN4ZTBjZ1VHM3RvTTI3S1NtOWxONG1pdmJNTl80NGd0eDluc3JOOFVuVHViR0JISzZRQ1JrVm0xX3BINkM3N2lMUnlnM1c0?oc=5","date":"2023-08-04","type":"pipeline","source":"Drug Delivery Business","summary":"Kindeva wins £33M grant from UK to enhance drug-delivering inhalers - Drug Delivery Business","headline":"Kindeva wins £33M grant from UK to enhance drug-delivering inhalers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFBjR2w5a1NZMVV2Wnk2XzRSeFZqV3p5QXBNRlhNbm5zY0RHbFZhRUJGajVhYTljNUpBb2dWbkhOdzRidV9tSFBoSUZPYkdmUzh3WGJLaWJvdGU3QXQ0OFdOTDBBbHZfX0RpaW91QWt3OHFval9pS2swdQ?oc=5","date":"2023-04-12","type":"pipeline","source":"PharmTech.com","summary":"Interview with Meridian’s Milton Boyer - PharmTech.com","headline":"Interview with Meridian’s Milton Boyer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOYjgxOHVUM1NGVGw3LVp6LVoxV1Q0YkdmRVl0MDVkZUNIMDczUXFrWWNubDNtWUF5SDhRTXQ5LXRoVENtV2R3V3J0MVdmczZDaW5JcC01dmxrMUhJNjVNZy1GT2dMN2FZcFhmNEVybzViWW9RNThGN2xxSUo3R1RsX2Q3SERHazVrbjVlN25GQk56QjlwNEN1ZXowUlc0WThoTEdydDYwWnplUQ?oc=5","date":"2022-11-15","type":"pipeline","source":"Star Tribune","summary":"Kindeva Drug Delivery to merge with St. Louis medical technology firm - Star Tribune","headline":"Kindeva Drug Delivery to merge with St. Louis medical technology firm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNN3l4M3gzQVhuV3RfQjBZWGF1ZHZGdzZXT29taUpUUkVxWW5yZTNiZ1NhYm5UcVZ1bWx5QVAxcmlnN0tXRHVJTmtwS3ZCaU41LXZ1Zm9PbzU3ZnhLRWQ4czlKZ1RENWdRWlRSVmQ4VWI2d1hpaFJlTEtKeHpjc1lGMEJhS0RfRlVqRGN1Y0owTnBiak1IUmRQTVBPWQ?oc=5","date":"2022-06-17","type":"deal","source":"Star Tribune","summary":"Woodbury-based Kindeva, a 3M spinoff, acquires iPharma Labs - Star Tribune","headline":"Woodbury-based Kindeva, a 3M spinoff, acquires iPharma Labs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQcm1LLVZoXzNKQXJvdVZ3MmRsSDI5amFldnZHaEJxdTJTV1BJeHlSNjRMUHVjcDdCcjZpYUM1Zllha0F6ZzQyT0pMUVdtSGJ1a1VqWmZtZ1F6Q05WVXR6U0VSRHB5YlJYek5VLWJwSWNnOEpaaXdIc3gwRXZHSUpwNlJFVFZEZkY2TE1ZYWhnRmE4YjdZeHFWQ21HaVBkelZhQm5tbTRobXJJVUFEZTJFUi0zNzA4X0lxRmlmZ0ZmX1BIZw?oc=5","date":"2020-05-04","type":"pipeline","source":"TheBusinessDesk.com","summary":"New jobs on the way as pharma firm launches as independent company - TheBusinessDesk.com","headline":"New jobs on the way as pharma firm launches as independent company","sentiment":"neutral"}],"patents":[{"drugName":"EpiPen","drugSlug":"epinephrine-auto-injector","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":1500000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Catalent","Piramal Pharma Solutions","Recro Pharma"],"therapeuticFocus":["Pain Management","Respiratory Diseases"],"financials":null,"yahoo":null}